U. Rebmann

Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

Thomas Wiegel, Dirk Bottke, Ursula Steiner et al. · Journal of Clinical Oncology · 2009 · 824 citations

Medicine, Surgery, Urology +12

Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial

Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke et al. · European Urology · 2014 · 446 citations

Medicine, Surgery, Urology +13

Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

Jens Atzpodien, Hartmut Kirchner, Udo Jonas et al. · Journal of Clinical Oncology · 2004 · 225 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma.

Jens Atzpodien, E Lopez Hänninen, H. Kirchner et al. · Journal of Clinical Oncology · 1995 · 142 citations

Medicine, Oncology, Pharmacotherapy +16

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

C. Oberhoff, B Neri, D. Amadori et al. · Annals of Oncology · 1998 · 110 citations

Medicine, Hematology, Pharmacology +15